Guerbet S.A. (0ELV.L)
0ELV.L Stock Price Chart
Explore Guerbet S.A. interactive price chart. Choose custom timeframes to analyze 0ELV.L price movements and trends.
0ELV.L Company Profile
Discover essential business fundamentals and corporate details for Guerbet S.A. (0ELV.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
4 Aug 2008
Employees
2.78K
Website
https://www.guerbet.comCEO
David Hale
Description
Guerbet SA engages in the development and marketing of contrast media products, delivery systems, medical devices, and related solutions. The company offers Optiray and Xenetix, which are non-ionic monomeric and iodinated contrast agents; Telebrix Gastro, a meglumine ioxitalamate solution; Conray, an iothalamate meglumine injection; Micropaque/Microtrast, a diagnostic imaging interconnected solution; Dotarem, a gadoteric acid-gadoterate meglumine, and Artirem, a gadoteric acid that acts as a contrast agent for MRI, as well as prefilled syringes, injectors, accessories, and consumables for MRI, CT, and Cath Lab. It also provides digital solutions, such as Contrast&Care, an injection management solution; Dose&Care, an X-ray dose management solution; and icobrain, a cloud-based AI solution to quantify disease-specific brain structures for acute and chronic neurological conditions on MR and CT, as well as OptiProtect services. In addition, the company provides products for interventional radiology, including Lipiodol ethyl esters of iodinated fatty acids of poppyseed oil; Vectorio, a mixing and injection system for conventional trans-arterial chemoembolization; Patent Blue V, a blue dye; Axessio, a peripheral micro guidewire; and SeQure and DraKon, which are microcatheters. Further, it offers Hydra Vision, a digital imaging system for urological, gastroenterological, and gynecological treatment, as well as planning and diagnostic procedures; and urology accessories and consumables. The company was founded in 1926 and is headquartered in Villepinte, France.
0ELV.L Financial Timeline
Browse a chronological timeline of Guerbet S.A. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 24 Mar 2026
Upcoming earnings on 24 Sept 2025
Earnings released on 26 Mar 2025
EPS came in at €0.41, while revenue for the quarter reached €421.91M.
Earnings released on 24 Oct 2024
EPS came in at €0.87, while revenue for the quarter reached €424.92M, beating expectations by +77.35%.
Dividend declared on 1 Jul 2024
A dividend of €0.50 per share was announced, adjusted to €0.50. The dividend was paid on 3 Jul 2024.
Earnings released on 18 Apr 2024
EPS came in at €1.80, while revenue for the quarter reached €415.87M.
Earnings released on 30 Jun 2023
EPS came in at €0.17, while revenue for the quarter reached €378.63M, beating expectations by +0.02%.
Dividend declared on 29 Jun 2023
A dividend of €0.50 per share was announced, adjusted to €0.50. The dividend was paid on 3 Jul 2023.
Earnings released on 31 Dec 2022
EPS came in at -€3.52, while revenue for the quarter reached €382.20M.
Earnings released on 30 Jun 2022
EPS came in at €0.26, while revenue for the quarter reached €371.07M, missing expectations by -0.01%.
Dividend declared on 29 Jun 2022
A dividend of €0.85 per share was announced, adjusted to €0.85. The dividend was paid on 5 Jul 2022.
Earnings released on 31 Dec 2021
EPS came in at €0.73, while revenue for the quarter reached €368.96M.
Earnings released on 30 Jun 2021
EPS came in at €1.85, while revenue for the quarter reached €363.11M, beating expectations by +0.67%.
Dividend declared on 29 Jun 2021
A dividend of €0.70 per share was announced, adjusted to €0.70. The dividend was paid on 1 Jul 2021.
Earnings released on 31 Dec 2020
EPS came in at €0.75, while revenue for the quarter reached €348.64M.
0ELV.L Stock Performance
Access detailed 0ELV.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.